• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Titan Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4349.0
  • ISIN : INE150C01011
423.35 -4 (-0.87%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    411.55

  • Today’s High

    437.00

  • Open

    425.10

  • Perv Close

    427.05

  • 52W Low

    373.65

  • 52W High

    1,017.85

Key Indicators

  • P/E(TTM)

    19.15

  • Mar.Cap (₹Cr.)

    349.84

  • Div & Yield %

    0.47

  • Book Value(₹)

    175.63

  • Debt-Equity Ratio

    -0.87

  • AGM Date

    01-Aug-2025

  • EPS

    22.11

  • P/E Ratio

    19.15

Financials Ratios

  • Debt-Equity Ratio

    0.07

  • Mar.Cap (₹Cr.)

    349.84

  • RONW (%)

    19.44

  • ROCE (%)

    24.84

Score Board

  • Equity (₹ in Cr.)

    8.26

  • BV (₹)

    175.60

  • Sales( ₹ in Cr.)

    156.45

  • NP (in Cr.)

    18.27

  • NP Var(%)

    -23.0

  • Div%

    20.0

  • CPS (₹)

    27.20

  • EPS (₹)

    22.10

  • Traded Value (₹ in Lakhs)

    349.84

  • 52 Week High

    1,017.85

  • 52 Week Low

    373.65

  • Price BSE

    423.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    349.84

  • P/C Ratio

    15.60

  • P/E Ratio

    19.10

  • Price Vs.BV

    22.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 164.07 144.00 123.55 122.46 69.48 58.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 164.07 144.00 123.55 122.46 69.48 58.24
Other Income 1.75 1.94 0.94 0.75 1.02 0.65
Stock Adjustments 5.29 0.93 0.17 2.23 0.65 3.88
Total Income 171.11 146.87 124.66 125.44 71.15 62.77
EXPENDITURE :            
Raw Materials 85.33 74.61 61.64 57.58 36.75 34.50
Power and Fuel Cost 10.24 8.98 6.67 4.10 3.53 3.22
Employee Cost 23.71 18.21 14.24 11.08 9.07 7.65
Other Manufacturing Expenses 4.10 3.44 2.96 3.77 1.36 0.70
Selling and Administration Expenses 10.75 9.21 6.42 5.66 8.40 8.09
Miscellaneous Expenses 0.95 0.96 0.52 1.05 0.15 0.50
Employee Benefit Expenses 23.71 18.21 14.24 11.08 9.07 7.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 135.07 115.42 92.46 83.23 59.25 54.66
Operating Profit 36.03 31.47 32.21 42.20 11.90 8.11
Interest 1.17 0.75 0.87 1.33 1.91 2.08
Gross Profit 34.86 30.72 31.34 40.87 9.99 6.03
Depreciation 3.33 2.60 2.37 2.10 1.75 1.68
Profit Before Tax 31.53 28.12 28.97 38.77 8.24 4.35
Current Tax 7.76 7.18 7.35 9.86 1.85 1.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.11 -0.09 -0.07 0.13 0.19 0.25
Reported Net Profit 23.66 21.02 21.68 28.77 6.20 3.08
Extraordinary Items 0.00 0.00 0.00 -0.24 0.46 -0.05
Adjusted Net Profit 23.66 21.02 21.68 29.01 5.74 3.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 89.00 69.22 48.77 20.83 14.62 11.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.49 1.24 1.24 0.83 0.00 0.00
P & L Balance carried down 111.18 89.00 69.22 48.77 20.83 14.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 18.00 15.00 15.00 10.00 0.00
Dividend Per Share(Rs) 2.00 1.80 1.50 1.50 1.00 0.00
Earnings Per Share-Unit Curr 28.64 25.44 26.24 34.82 7.50 3.73
Earnings Per Share(Adj)-Unit Curr 28.64 25.44 26.24 34.82 7.50 3.73
Book Value 155.43 128.38 104.36 79.65 45.76 38.31
Book Value(Adj)-Unit Curr 155.43 128.38 104.36 79.65 45.76 38.31

Shareholding Pattern

  • Promoter Group

    55.88%

  • Public Share Holding

    44.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,120,610 49.86 4,120,610 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 496,905 6.01 496,905 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,617,515 55.88 4,617,515 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,319 0.03 2,319 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,319 0.03 2,319 1
2] Non Institution
Bodies Corporate 151,733 1.84 147,733 48
Clearing Members 50 0.00 50 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 197,114 2.39 197,114 337
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 96,563 1.17 96,563 171
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 285,081 3.45 285,081 5
Individuals holding nominal share capital up to Rs. 1 lakh 2,147,942 25.99 1,904,931 15,749
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 764,983 9.26 764,983 1
Sub Total 3,643,866 44.09 3,396,855 16,313
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,263,700 100.00 8,016,689 16,328

Company Background

Titan Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Titan Biotech Ltd
  • BSE Code : 4349.0
  • ISIN : INE150C01011

  • Incorporation Year

    1992

  • Registered Office

    A-902 A RIICO Industrial Area
    Phase III Alwar District, Bhiwadi,
    Rajasthan-301019

  • Telephone

    91-011-27355742/27674615

  • FAX

    91-011-47619811

  • Chairman

    Rohit Jain

  • Managing Director

    Naresh Kumar Singla

  • Company Secretary

    Charanjit Singh

  • Auditor

    A N S K & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99 ,
    Madangir Behind LSC ,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Titan Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Titan Biotech 423.35 165.82 164.07 19.15 25.70
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10